Week in Review: May 6

The Week in Review provides an overview of the past week’s top health care content, including industry news and trends, Mayo Clinic and Mayo Clinic Laboratories news, and upcoming events.

Industry News

Minnesota physicians brace for Roe v. Wade decision

A backlog of five patients is waiting for Dr. Sarah Traxler when she arrives with her security detail at the Planned Parenthood Clinic on the west side of town. These trips could end suddenly if the U.S. Supreme Court this spring overturns Roe v. Wade, the 1973 landmark case that made abortion legal in every state. Via Star Tribune

Read article.

Omicron subvariants can evade immunity from past infection, study says

Two new omicron subvariants being tracked by the WHO can evade antibodies from both previous infections and vaccinations, a South African study shows. Antibody effectiveness was lowest in patients who were not vaccinated. Via Axios

Read article.

FDA: “No Evidence” Second Pfizer COVID Pill Stops Repeat Symptoms, Contradicting CEO

An FDA official contradicted Pfizer saying that a second round of Paxlovid would be unlikely to help patients with rebounding symptoms. The FDA reiterated that the main purpose of Paxlovid is to prevent severe COVID-19.  Via Axios

Read article.

Mayo Clinic News

An algorithm that analyzes Apple Watch data shows early promise in detecting heart problems

Mayo Clinic is developing an algorithm capable of detecting a weak heart pump from electrocardiograms recorded on wearable devices like Apple Watches, potentially enabling early detection of the life-threatening condition outside medical settings. The algorithm accurately flagged a small number of patients with a weak heart pump in a study presented Sunday at the annual Heart Rhythm Society conference in San Francisco. Via STAT

Read article.

Mayo Clinic: Mental health needs rise as pandemic fluctuates

Primary care physicians are often the first stop for many patients who seek help with their mental health. Dr. Jay-Sheree Allen, a family medicine physician at Mayo Clinic, said that’s one of the main reasons patients are making appointments. “We’re seeing a lot in the primary care setting now related to mental health issues, particularly major depressive disorder, generalized anxiety disorder and post-traumatic stress disorder.” . Via Atlantic Journal-Constitution

Read article.

Chronic diseases are more likely to develop in these groups of people with anxiety and depression

Researchers were not able to determine why women were more likely to be affected than men, but there are some possible hypotheses, said study author Dr. William Bobo, professor of psychiatry, and chair and consultant of the department of psychiatry and psychology at the Mayo Clinic in Jacksonville, Florida. “There are sex differences in the frequency of diagnosed anxiety and depressive disorders and that may have played a role,” he said. Via CNN

Read article.

Meghann Southwick

Meghann Southwick is a marketing specialist for Mayo Clinic Laboratories. She has worked at Mayo Clinic since 2021.